The tools ideate on Boston Scientific’s Farapulse PFA system, which contributed towards a 172% uptick in the company’s Q4 ...

Boston Scientific Corporation BSX, despite industrywide macroeconomic upheavals, has been seeing strong growth momentum ...

Investing.com -- Boston Scientific Corp (NYSE: BSX ). has had its issuer credit rating and its issue-level rating on its senior unsecured debt upgraded to 'A-' from 'BBB+' by S&P Global Ratings. This ...

Nations Financial Group Inc. IA ADV trimmed its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 5.9% in the ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter.

Argus raised the firm’s price target on Boston Scientific (BSX) to $130 from $105 and keeps a Buy rating on the shares. The firm sees strong ...

Argus Research analyst David Toung maintained a Buy rating on Boston Scientific (BSX – Research Report) on February 14. The company’s shares ...

Boston Scientific announced won CE mark for its navigation-enabled Farawave Nav ablation catheter and Faraview software.

Jeffrey B. Mirviss, Executive Vice President and President of Peripheral Interventions at Boston Scientific Corp (NYSE:BSX), ...

At the town hall of the annual gathering of the American Association for the Advancement of Science, Trump’s name was largely ...